The former global development head of Sanofi (SNY.US) has joined Gilead (GILD.US).

Before joining Gilead (GILD.US), Dr. Dietmar Berger served as CMO and Global Development Head at Sanofi (SNY.US).

Zhitong Finance27minutes ago

Gilead Sciences (GILD) Stock Moves -0.57%: What You Should Know

Zacks Dec 14 06:15

Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report

BenzingaDec 14 01:15

Truist Financial Maintains Gilead Sciences(GILD.US) With Hold Rating

Futu NewsDec 13 20:31 · Ratings

Gilead Sciences (GILD) Gets a Hold From Truist Financial

TipRanksDec 13 20:17 · Ratings

Gilead Gets Key European Backing for Liver-Disease Treatment

WSJDec 13 20:04